Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
132.06
+1.13 (0.86%)
At close: Aug 7, 2025, 4:00 PM
132.27
+0.21 (0.16%)
After-hours: Aug 7, 2025, 7:49 PM EDT
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of $229.85 billion as of August 7, 2025. Its market cap has increased by 27.14% in one year.
Market Cap
229.85B
Enterprise Value
236.03B
1-Year Change
27.14%
Ranking
Category
Stock Price
$132.06
Market Cap Chart
Since December 1, 1998, Abbott Laboratories's market cap has increased from $72.66B to $229.85B, an increase of 216.31%. That is a compound annual growth rate of 4.41%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 7, 2025 | 229.85B | 17.16% |
Dec 31, 2024 | 196.18B | 2.67% |
Dec 29, 2023 | 191.09B | -0.18% |
Dec 30, 2022 | 191.43B | -23.08% |
Dec 31, 2021 | 248.87B | 28.25% |
Dec 31, 2020 | 194.06B | 26.33% |
Dec 31, 2019 | 153.61B | 20.92% |
Dec 31, 2018 | 127.04B | 27.88% |
Dec 29, 2017 | 99.34B | 75.66% |
Dec 30, 2016 | 56.55B | -15.59% |
Dec 31, 2015 | 66.99B | -1.18% |
Dec 31, 2014 | 67.79B | 14.39% |
Dec 31, 2013 | 59.27B | -42.76% |
Dec 31, 2012 | 103.53B | 18.20% |
Dec 30, 2011 | 87.59B | 18.28% |
Dec 31, 2010 | 74.06B | -11.31% |
Dec 31, 2009 | 83.51B | 0.85% |
Dec 31, 2008 | 82.81B | -4.56% |
Dec 31, 2007 | 86.77B | 16.06% |
Dec 29, 2006 | 74.76B | 22.23% |
Dec 30, 2005 | 61.16B | -15.81% |
Dec 31, 2004 | 72.65B | -0.27% |
Dec 31, 2003 | 72.85B | 16.56% |
Dec 31, 2002 | 62.50B | -27.79% |
Dec 31, 2001 | 86.55B | 15.52% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 687.62B |
Johnson & Johnson | 411.20B |
AbbVie | 350.75B |
AstraZeneca | 231.42B |
Novartis AG | 228.98B |
UnitedHealth Group | 227.69B |
Novo Nordisk | 210.71B |
Merck & Co. | 202.87B |